Skip to navigation Skip to content

Clinical Trial: Zoom intervention for depression and anxiety

Share

Details
Type of MS: PPMS|PRMS|RRMS|SPMS
Treatment mode of action: To reduce depression and anxiety
Number of Subjects: 24
Medication: Behavioral intervention
Location: Alabama|Alaska|Arizona|Arkansas|California|Colorado|Connecticut|Delaware|District of Columbia|Florida|Georgia|Hawaii|Idaho|Illinois|Indiana|Iowa|Kansas|Kentucky|Louisiana|Maine|Maryland|Massachusetts|Michigan|Minnesota|Mississippi|Missouri|Montana|Nebraska|Nevada|New Hampshire|New Jersey|New Mexico|New York|North Carolina|North Dakota|Ohio|Oklahoma|Oregon|Pennsylvania|Rhode Island|South Carolina|South Dakota|Tennessee|Texas|Utah|Vermont|Virginia|Washington|West Virginia|Wisconsin|Wyoming
Institutions: Kessler Foundation Contact Information
Belinda Washington
973-324-8446
bwashington@kesslerfoundation.org

Funding:

Kessler Foundation donors

Description

Researchers at Kessler Foundation are studying whether an intervention aimed a treating depression and anxiety may result in improved psychological well-being, coping, and quality of life among individuals with multiple sclerosis (MS). Participation will involve attending 12 weeks of a group, online informational series, which will be conducted via Zoom. Participants will also complete a series of online assessments (taking approximately one hour) immediately prior to and following the intervention and 3 months later. Participants will be compensated for their time.

For more information or to see if you are eligible, please contact Lauren Vitale at 973-323-3748 or lvitale@kesslerfoundation.org

Share

© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.